Approval · Notice of Compliance 9879 · 2008
NEUROLITE: Notice of Compliance 9879
Issued November 7, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9879
- Date
- November 7, 2008
- Company
- Lantheus Mi Canada IncMontreal, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Radiodiagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEUROLITE | Not yet assigned | — |
Medicinal ingredients
- BICISATE DIHYDROCHLORIDE 0.9 MG per VIAL